NASDAQ · Biotechnology

Ardelyx, Inc. (ARDX) Stock

$3.08 -3.75% NASDAQ: ARDX Healthcare

Valuation

MetricValue
Price$3.08
Market Cap$767.50M
P/E Ratio-15.13
P/B Ratio5.69
P/S Ratio1.87
EPS (TTM)$0.52
52-Week High$8.40
52-Week Low$3.04
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-36.00%
ROA-9.67%
ROCE-7.99%
Gross Margin91.93%
Operating Margin-8.75%
Net Margin-12.35%
Debt/Equity1.72
Current Ratio4.29

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$52.0M$124.0M$334.0M$407.0M
Operating Profit$-154.0M$-64.0M$-63.0M$-28.0M$-41.0M
Net Profit$-158.0M$-67.0M$-66.0M$-39.0M$-62.0M
EPS$-1.52$-0.42$-0.30$-0.17$-0.26
Op Margin-1528.6%-122.2%-50.8%-8.4%-10.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$150.0M$190.0M$298.0M$436.0M$502.0M
Total Liabilities$67.0M$92.0M$131.0M$262.0M$335.0M
Cash$72.0M$96.0M$21.0M$65.0M$68.0M
Borrowings$46.0M$36.0M$56.0M$153.0M$212.0M

Latest News

ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle Stocktwits · Jun 26, 2026 Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last? Zacks · Jun 24, 2026 Ardelyx Stock Up 70%: What to Know About This $490,000 Insider Transaction Motley Fool · Jun 23, 2026 What’s Fueling Optimism Around Ardelyx, Inc. (ARDX)’s Sales and Pipeline? Insider Monkey · Jun 23, 2026 Ardelyx Insider Sold Shares Worth $490,487, According to a Recent SEC Filing MT Newswires · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-153.0M$-70.0M$-90.0M$-45.0M$-42.0M
Investing Cash Flow$49.0M$18.0M$-132.0M$-19.0M$-10.0M
Financing Cash Flow$1.0M$10.0M$5.0M$-1.0M$0
Net Cash Flow$-19.0M$24.0M$-75.0M$43.0M$3.0M
Free Cash Flow$-154.0M$-70.0M$-90.0M$-46.0M$-44.0M

Valuation & Return Ratios

MetricValue
PEG Ratio6.17
EV / EBITDA-42.16
FCF Yield-2.12%
Quick Ratio3.15
Interest Coverage-1.29
Return 1Y16.86%
Return 3Y46.99%
Return 5Y-31.11%

Ownership

Insiders Held3.28%
Institutions Held70.76%
Institutions Float Held73.16%
Institutional HolderSharesReport Date
Blackrock Inc.21,164,1322026-03-31
Millennium Management Llc17,842,3702026-03-31
State Street Corporation13,604,3072026-03-31
Vanguard Capital Management LLC10,365,5122026-03-31
Janus Henderson Group PLC8,371,2342026-03-31

About Ardelyx, Inc.

Ardelyx, Inc. is led by CEO Michael G. Raab, employs 395 people, headquartered in US, publicly traded since 2014.

Ardelyx, Inc. (ARDX) stock trades at $3.08 with a market capitalization of $767.50M. The stock is valued at a negative price-to-earnings (P/E) ratio of -15.13, reflecting a net loss over the last twelve months, price-to-book of 5.69, price-to-sales of 1.87. Over the past 52 weeks the stock has ranged between $3.04 and $8.40, and currently trades 63.3% below its 52-week high.

On profitability, Ardelyx, Inc. generates a return on equity (ROE) of -36.00% (negative, reflecting a net loss), return on capital employed of -7.99%, an operating margin of -8.75%, a net profit margin of -12.35%.

Ardelyx, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Ardelyx, Inc. reported revenue of $24.0M rising to $407.0M, a change of +1595.8% across 10 years. Compounded, revenue has grown 119.4% a year over five years, 98.5% over three, 21.9% over the last twelve months. Net profit rose to $-62.0M.

Operating margin went from -469.9% in 2016 to -10.1% in 2025, a gain of 459.8 percentage points. The most recent net margin is -12.35%. On a trailing twelve-month basis to Jun '26, revenue is $450.0M and net profit $-56.0M.

Borrowings stand at $212.0M, cash from operations was $-42.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged -71.6% over five years, and was -37.1% in the most recent year.

The share price itself has compounded at -4.9% a year over five years, 15.1% over three, 57.9% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Ardelyx, Inc. (ARDX) — frequently asked questions

What is Ardelyx, Inc. (ARDX) stock price today?

Ardelyx, Inc. (ARDX) is currently trading at $3.08, down 3.75% today.

What is ARDX P/E ratio?

Ardelyx, Inc.'s P/E ratio is -15.13. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is ARDX return on equity (ROE)?

Ardelyx, Inc.'s return on equity (ROE) is -36.00%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Ardelyx, Inc.'s market cap?

Ardelyx, Inc. has a market capitalization of $767.50M.

Does ARDX pay a dividend?

Ardelyx, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does ARDX carry?

Ardelyx, Inc. has a debt-to-equity ratio of 1.72. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is ARDX's profit margin?

Ardelyx, Inc. reports a net profit margin of -12.35% — the share of revenue left after every cost, including tax and interest.

What sector is ARDX in?

Ardelyx, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is ARDX listed on?

Ardelyx, Inc. trades on NASDAQ under the ticker ARDX.

What is ARDX's 52-week range?

Over the last year Ardelyx, Inc. has traded between $3.04 and $8.40.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens ARDX currently matches

On the figures above, Ardelyx, Inc. passes the filters for 8 of our ready-made screens, among them Penny Stocks, Small Cap Stocks, Stocks Under $5. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksSmall Cap StocksStocks Under $5Stocks Under $10Stocks Under $100Stocks Under $50High Gross Margin StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.